Author:
Su Alex,Albarran Garcia Daisy,Li Mandy,Ogbonna Chinyere,Tsang Thomas,Tsang Alex,Bantug Chynna,Tom Wynnyee,Harris Brooke
Abstract
Vaping nicotine and marijuana have been increasing among adolescents in the past 5 years. Tetrahydrocannabinol is the psychoactive cannabinoid in marijuana. The COVID-19 pandemic created gaps in healthcare access and visits, making it difficult to collect accurate data on adolescent vaping, willingness to quit and methods used to quit. In addition, the literature lacks information regarding effective evidence-based treatment measures for adolescents who vape. In this report, we seek to address this using two patient cases and detailing the interventions a managed care organisation enacted during this timeframe. Our investigation revealed a relationship between social stressors and vaping among teens. Addressing these underlying stressors and eliciting and treating mental health symptoms and polysubstance use appears to be critical to curbing vaping.
Reference10 articles.
1. Scheck T , Srivastava H . As concerns rise over youth vaping, Juul quickly puts together an army of lobbyists. Juul Muscles Up | APM Reports. 2022. Available: https://www.apmreports.org/story/2019/09/17/juul-lobbying-youth-vaping [Accessed 31 Jan 2022].
2. Trends in use and perceptions of nicotine vaping among US youth from 2017 to 2020;Miech;JAMA Pediatr,2021
3. The future of substance abuse now: relationships among adolescent use of vaping devices, marijuana, and synthetic cannabinoids;Tai;Subst Use Misuse,2021
4. Effectiveness of an educational intervention on health risks of vaping for high school-aged adolescents;Chaplin;J Am Pharm Assoc (2003),2020
5. US surgeon general’s report: preventing tobacco use among youth and young adults. 2012. Available: http://www.surgeongeneral.gov/library/reports/preventing-youth-tobacco-use/